Skip to content
Clinical Trials for Alzheimer's Disease

Maryland

Alzheimer's disease clinical trials in Maryland

18 Alzheimer's disease studies are recruiting participants at sites in 5 cities across Maryland as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Maryland city with a recruiting study

Baltimore (12), Bethesda (2), Gaithersburg (2), Germantown (1), Pikesville (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Maryland

Basic details from each study's public record (the 12 most recently updated of 18). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)

    • Observational
    • Ages 55 to 110
    • All sexes
    Sponsor
    National Institute on Aging (NIA)
    Recruiting in
    Baltimore
    Registry record
    NCT07099053 · updated
  2. PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

    • Phase 1
    • Ages 50 to 100
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Recruiting in
    Bethesda
    Registry record
    NCT07169630 · updated
  3. Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

    • Phase 2
    • Ages 65 to 120
    • All sexes
    Sponsor
    National Institute on Aging (NIA)
    Recruiting in
    Baltimore
    Registry record
    NCT07721467 · updated
  4. HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

    • No phase
    • Ages 60 to 100
    • All sexes
    Sponsor
    Johns Hopkins University
    Recruiting in
    Baltimore
    Registry record
    NCT06930560 · updated
  5. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Gaithersburg
    Registry record
    NCT07011732 · updated
  6. ACP-204 in Adults With Alzheimer's Disease Psychosis

    • Phase 2/3
    • Ages 55 to 95
    • All sexes
    Sponsor
    ACADIA Pharmaceuticals Inc.
    Recruiting in
    Gaithersburg
    Registry record
    NCT06159673 · updated
  7. PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Recruiting in
    Bethesda
    Registry record
    NCT04396873 · updated
  8. Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    • Phase 2
    • Ages 55 to 80
    • All sexes
    Sponsor
    Lighthouse Pharmaceuticals, Inc.
    Recruiting in
    Pikesville
    Registry record
    NCT06847321 · updated
  9. Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

    • Early Phase 1
    • Ages 18 to 85
    • All sexes
    Sponsor
    Johns Hopkins University
    Recruiting in
    Baltimore
    Registry record
    NCT04123314 · updated
  10. Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Johns Hopkins University
    Recruiting in
    Baltimore
    Registry record
    NCT05556395 · updated
  11. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Recruiting in
    Baltimore
    Registry record
    NCT06563895 · updated
  12. Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

    • Phase 2
    • Ages 55 and older
    • All sexes
    Sponsor
    Johns Hopkins University
    Recruiting in
    Baltimore
    Registry record
    NCT04601038 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Maryland on ClinicalTrials.gov.

Ask about studies in Maryland

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call